Effect of anti-inflammatory drugs on collagen-induced autoimmune inner ear disease

Annals of Otology, Rhinology & Laryngology

Volumn 97, Issue 2, 1988, Pages 153-158

  Sudo, Naohiro ^a   Yoo, T J ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

anti inflammatory drugs; autoimmune ear disease; hearing loss; type II collagen

Indexed keywords

COLLAGEN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; SULINDAC;

ANIMAL EXPERIMENT; AUTOIMMUNE DISEASE; HEARING LOSS; INNER EAR DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; RAT;

ANIMAL; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; AUTOIMMUNE DISEASES; COCHLEA; COLLAGEN; COMPLEMENT 3; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN G; LABYRINTH DISEASES; METHYLPREDNISOLONE HEMISUCCINATE; RATS; RATS, INBRED LEW; SULINDAC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0023892887     PISSN: 00034894     EISSN: 19433572     Source Type: Journal    
DOI: 10.1177/000348948809700212     Document Type: Article

References (16)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585–9
2. Hughes GB Kinney SE Barna BP Tomsak RL Calarese LH. Autoimmune reactivity in Cogan's syndrome: A preliminary report. Otolaryngol Head Neck Surg 1983; 91: 24–32
3. Yoo TJ Tomoda K Stuart JM Cremer MA Townes AS Kang AH. Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol 1983; 92: 267–71
4. Yoo TJ Stuart JM Kang AH Townes AS Tomoda K. Type II collagen autoimmunity in otosclerosis and Meniere's disease. Science 1982; 217: 1153–5
5. Stuart JM Cremer MA Dixit SN Kang AH Townes AS. Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagen. Arthritis Rheum 1979; 22: 347–52
6. Yoo TJ Floyd RA Sudo N, et al, Factors influencing collagen-induced autoimmune ear disease. Am J Otolaryngol 1985; 6: 209–16
7. Dick WC DeCeulaer K. Clinical pharmacology. In: Kelly WN, Harris EDJr., Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1981: 768–80
8. Hughes GB Kinney SE Barna BP Calabrese LH. Practical versus theoretical management of autoimmune inner ear disease. Laryngoscope 1984; 94: 758–67
9. Veldman JE Roord JJ O'Connor AF Shea JJ. Autoimmunity and inner ear disorders: An immune-complex mediated sensorineural hearing loss. Laryngoscope 1984; 94: 501–7
10. Kanzaki J Ouchi T. Steroid-responsive bilateral sensorineural hearing loss and immune complexes. Arch Otorhinolaryngol 1981; 230: 5–9
11. Parrilio JE Fauci AS. Mechanisms of glucocorticoid action on immune process. Ann Rev Pharmacol Toxicol 1979; 19: 179–201
12. Fauci AS Dale DC Balow JE. Glucocorticosteroid therapy: Mechanism of action and clinical considerations. Ann Intern Med 1976; 84: 304–15
13. Gryglewski RJ. Steroid hormones, anti-inflammatory steroids and prostaglandins. Pharmacol Res Commun 1976; 8: 337–48
14. Schiff M Yoo TJ. Immunologic aspects of otologic disease: An overview. Laryngoscope 1985; 95: 259–69
15. Jung TTK Juhn SK. Prostaglandins in the perilymph. In: Abstracts of the Seventh Midwinter Research Meeting, St Petersburg, Fla: Association for Research in Otolaryngology, 1984: 107
16. Kitano H Takeda T Chiang T Yoo TJ. Prostaglandin in the perilymph of collagen induced ear disease. Presented at the meeting of the Association for Research in Otolaryngology, Clearwater, Fla, February 1987